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Summary
Endoglin is an auxiliary receptor for TGFβ signalling. Heterozygous germline Endoglin mutations
have been identified in patients with the vascular abnormality, Hereditary Haemorrhagic
Telangiectasia. Endoglin is upregulated in endothelial cells during angiogenesis and loss of Endoglin
in the mouse results in embryonic lethality at mid-gestation. This phenotype points to an important
role of Endoglin in new blood vessel formation but precludes analysis at later stages in development
and in postnatal life. To bypass this limitation and allow further investigations of the function of
Endoglin we have generated a floxed Endoglin allele in which loxP sites flank exons 5 and 6. Mice
homozygous for this allele are normal and in the presence of appropriate Cre lines will allow time
and cell specific Endoglin deletion for in vivo analysis of function in cardiovascular development
and disease.
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Endoglin is a transmembrane protein which is expressed primarily in endothelial cells. It
interacts with receptors of the TGFβ family of ligands and promotes signaling through activin
like kinase 1(ALK1) in response to TGFβ or BMP9 (David et al., 2007; Lebrin et al., 2004).
Patients heterozygous for mutations in Endoglin mutations develop the familial vascular
disorder Hereditary Haemorrhagic Telangiectasia (McAllister et al., 1995). Large
arteriovenous malformations may develop in major organs such as the lung or liver and
bleeding often occurs from small telangiectases in the nasal, oral, and gastrointestinal mucosa
(Guttmacher et al., 1995). This inherited disorder is also associated with mutations in ALK1
(Johnson et al., 1996), leading to the idea that Endoglin and ALK1 have common regulatory
functions in the vasculature. Endoglin is dynamically regulated and is expressed at higher levels
during developmental, physiological, or pathological angiogenesis compared with quiescent
blood vessels (Duff et al., 2003; Jonker and Arthur, 2002; Torsney et al., 2002). To study the
role of Endoglin, mice homozygous for null Endoglin alleles have been generated
independently in three different laboratories. All Endoglin null mice show early embryonic
lethality at 10.5–11.5 days post coitum (dpc) characterized by angiogenesis defects of the yolk
sac and abnormal heart development (Arthur et al., 2000; Bourdeau et al., 1999; Li et al.,
1999). The formation of the primitive vascular plexus in the yolk sac appears to occur normally
but the subsequent branching and remodeling associated with angiogenesis fails to proceed.
Further analysis of the Endoglin null embryos has shown that Endoglin is required for
downstream TGFβ signaling from the endothelial cell to the adjacent smooth muscle cell to
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promote smooth muscle cell differentation (Carvalho et al., 2004). This has raised the
interesting hypothesis that Endoglin is required for the stabilization of neo-vessels, but further
work is hampered by the early embryonic lethal phenotype of the Endoglin null mouse. In
parallel, the heterozygous Endoglin null mouse has been developed as a model of HHT. Clinical
symptoms similar to those of HHT patients can occur in up to 72% of mice but are highly
dependent on the presence or absence of modifier genes in the background strain (Bourdeau
et al., 2001; Torsney et al., 2003). To bypass some of these difficulties and to determine the
role of Endoglin in late developmental and adult life, we have generated a floxed Endoglin
mouse for conditional knockout studies.
The targeting construct was designed to allow conditional deletion of exons 5 and 6 of the
Endoglin gene which would also lead to a frameshift mutation in exon 7 and generate a null
allele. The targeting strategy, illustrated in Figure 1, shows the generation of a tri-floxed
Endoglin allele in which loxP sites flank a PGK-Neo cassette and exons 5 and 6 of the Endoglin
gene. Transfection of ES cells and subsequent PCR and southern blot screening of G418
resistant colonies, led to the derivation of two independent ES clones (clones 6 and 19) (Fig.
1). Mice generated from these clones were used as founders to breed mice that were
homozygous for the tri-floxed allele (Eng3fl). We were initially surprised to observe that these
mice had an embryonic lethal phenotype, indistinguishable from the conventional Endoglin
KO, and Endoglin protein was undetectable in homozygous Eng3fl/3fl embryos at 9.5 dpc (not
shown). This is consistent with the disruption of translation of the Endoglin gene by an abberant
splicing event, which has been reported to be up to 100% efficient when the PGK-Neo cassette
is in the reverse orientation, as in our design (Nagy, 2000).
We therefore proceeded to remove the neo cassette from heterozygous Eng3fl/+ mice in vivo
using the Meu-Cre40 transgenic mouse (Leneuve et al., 2003). This line produces a ubiquitous
low level of Cre activity allowing all three possible recombinant alleles to be derived from a
triple floxed allele. The breeding strategy is summarized in Figure 2A. Essentially mosaic F1
male mice, heterozygous for both the tri-floxed allele and the Meu-Cre40 transgene are
identified by PCR genotyping of genomic DNA prepared from sperm or ear tissue biopsy.
These mice are recognized by their mosaicism-all 3 possible recombinant alleles are present
within the tissues and can be detected by PCR. The required recombination event, the bifloxed
Endoglin allele with the neo cassette removed was detected using PCR primers y and z (Fig.
2B, upper panel, lane 3). These mosaics were then crossed with wild type C57Bl/6 females to
generate F2 mice and all possible recombination events were observed in the F2 generation.
To summarize, a total of 47 F2 mice had inherited the floxed Endoglin allele, but not the Meu-
Cre40 transgene, and of these, 5 mice (∼10%) had the required bifloxed Endoglin allele
(Eng2fl) without the neo cassette (shown in Fig. 2C). These Eng2fl/+ mice were then intercrossed
to generate homozygous Endoglin bifloxed mice (Eng2fl/2fl), which are viable and fertile, with
no obvious phenotype. This suggests that the loxP sites in introns 4 and 6 do not interfere with
normal expression of the Endoglin gene. Furthermore, compound heterozygotes carrying the
bifloxed allele and our previously published null Endoglin allele were also viable, showing
that the bifloxed allele was able to functionally rescue the Endoglin null allele.
The purpose of conditional alleles is only achieved if they are readily converted to a null allele
in the presence of Cre recombinase. Therefore, to formally show that removal of exons 5 and
6 from the bifloxed Endoglin allele generated an Endoglin null allele, we first crossed the
bifloxed mice with the ubiquitously expressed Cre line, PGK-Cre (Lallemand et al., 1998). In
PGK-Cre females, Cre recombinase is present in all oocytes irrespective of the presence of the
Cre transgene on the haploid chromosome set. When PGK-Cre females were crossed with
Eng2fl/+ males, the bifloxed allele recombined at 100% efficiency in the oocyte, to delete exons
5 and 6 and generate the EngΔex5–6 allele in the progeny (Fig. 3A). We then examined the
genotypes of progeny from an interheterozygous cross of EngΔex5-6/+ mice. A similar number
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of EngΔex5-6/Δex5-6 and wild type embryos were observed at 9.5 dpc consistent with expected
Mendelian ratios. However, there were no EngΔex5-6/Δex5-6 offspring among 54 neonates
examined (Table 1). This highly significant (P < 0.0001) deviation from the expected number
indicates that the EngΔex5-6/Δex5-6 offspring had an embryonic lethal phenotype. Further
analysis showed that embryos homozygous for the EngΔex5-6 allele die in mid-embryogenesis
with a phenotype indistinguishable from the conventional Endoglin knockout mice (Fig. 3). In
addition, immunohistochemical analysis shows that CD31 positive endothelial cells are present
in the EngΔex5-6/Δex5-6 9.5 dpc embryos but that Endoglin protein is not detected with the
MJ7/18 anti-Endoglin antibody (Fig. 3). If the EngΔex5-6 allele was translated, it would be
expected to produce a truncated peptide containing the extracellular domain of Endoglin
encoded by exons 1-4 with only 2 further amino acids encoded by a frameshifted sequence in
exon 7 before reaching a stop codon. Any truncated protein that may be present has no
transmembrane or C-terminal tail domain and previous data suggests truncated proteins of this
small size do not get processed to the cell surface and are unlikely to interfere with function
(Raab et al., 1999). Therefore EngΔex5-6 likely represents a null allele.
Endoglin is critical for cardiovascular development and its importance continues into adult life
during tissue remodelling and angiogenesis. For example, Endoglin is upregulated in healing
wounds in endothelial cells during angiogenesis and in myofibroblasts during collagen
synthesis (Torsney et al., 2002). It is expressed in endothelial progenitor cells where it has been
shown to be important in mediating cardiac repair (van Laake et al., 2006). It is upregulated
in tumor angiogenesis, where it represents a potentially valuable antiangiogenesis target (Duff
et al., 2003). It is also associated with the regulation of two important mediators of vascular
tone, enos, and cox-2, which may contribute to the pathobiology of HHT (Jerkic et al., 2006;
Toporsian et al., 2005). Endoglin therefore appears to be an important and multifunctional
protein critical for the development and function of the cardiovasculature. The bifloxed
Endoglin mouse described here provides a valuable tool for investigating the role of Endoglin
in vivo and for investigating its potential as a therapeutic target.
MATERIALS AND METHODS
Construction of the Targeting Vector
The targeting vector was assembled in pPNTlox2 which contains a floxed phosphoglycerol
kinase neomycin-resistance gene cassette (PGK-neo) for positive selection of recombinants
and a Thymidine kinase (Tk) gene to allow negative selection of ES cells that contain random
integration of the construct. The short arm containing exon 4 and part of intron 3 of the Endoglin
gene was prepared by PCR and cloned into the EcoRI site of pPNTlox2. The long arm
containing exons 5 to 11 was cloned into the NotI site of pPNTlox2. A third loxP site was
introduced into the HindIII site in intron 6 of the Endoglin gene. This cloning strategy leads
to the floxed PGK-neo cassette being present in the reverse orientation relative to the Endoglin
sequence (Fig. 1).
Electroporation of ES Cells and Generation of Chimeric Mice
Mouse E14 (129/ola) ES cells were electroporated with linearised targeting vector and selected
in G418-containing medium. The genotypes of G418-resistant ES clones were first analyzed
by PCR using the following primers (all DNA sequences are written in the 5′ to 3′ direction
and approximate locations are illustrated in the Figures). Primer-u
(ATGTGGCAGGTCTCAAGGTG) and Primer-v (ATCGCCTTCTATCGCCTTC) amplify a
1.8 kb product specific to the targeted recombinant allele, whilst primer-w
(GACGCCATTCTCATCCTGC) and primer-x (CCACGCCTTTGTCCTTGC) amplify
products of 430 bp from the wild type Endoglin allele and 500 bp from the floxed Endoglin
allele. Amplification was performed for 35 cycles with 15 s at 96°C, 30 s at 58°C, and 60 s at
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74°C. Further Southern blot analysis used 3′ and 5′ external probes to hybridize to EcoRI
digested genomic DNA, as previously described (Arthur et al., 2000). Ultimately two of 40
(5%) G418-resistant ES clones were found to be homologous recombinants and microinjected
into C57BL/6 blastocysts. The resulting chimeras were bred to C57BL/6 females, and germline
transmission of the floxed Endoglin allele was obtained.
Genotype Analysis
Ear biopsy (or sperm from mosaic males, taken directly from the uterus of a euthenased female
on the day following coitus) was used to prepare genomic DNA as previously described (Arthur
et al., 2000). Mouse genotypes were determined by PCR analysis using primers w and x above,
Cre primers Cre-F (GATCGCTGCCAGGATATACG) and Cre-R
(AATCGCCATCTTCCAGCAG) which gives a PCR product of 574 bp when a Cre transgene
is present; Primer-y (GGTCAGCCAGTCTAGCCAAG) and primer-z
(GTGGTTGCCATTCAAGTGTG) amplify products of 411 bp for the wild type allele and 566
bp for the bi-floxed Endoglin allele. PCR using primer-x with primer-y gives a product of 602
bp only in the presence of the EngΔex5-6 allele, and no detectable PCR product is amplified
from a wild-type allele.
Immunohistochemistry
For whole-mount immunohistochemistry, embryos were dissected from decidua and fixed in
4% paraformaldehyde/PBS at 4°C overnight before rinsing in 0.5%NP40/PBS and dehydration
to methanol. Embryos were bleached in 5% hydrogen peroxide in methanol for 1–2 h at room
temperature, before rehydration to PBS and blocking in PBSST (5% rabbit serum, 0.1% Triton
X-100, PBS). The embryos were incubated with primary antibody diluted in PBSST at 4°C
overnight. Primary antibodies, rat monoclonal MEC13.3 and MJ7/18 (BD Biosciences), were
used to detect CD31 and Endoglin protein, respectively. Embryos were extensively washed
with PBSST at 4°C and then incubated with biotinylated rabbit anti-rat secondary antibody
(Vector Labs) in PBSST at 4°C overnight. Embryos were washed extensively in PBSST at 4°
C, and finally in PBT (0.2% BSA, 0.1% Triton X-100, PBS) for 20 min at room temperature.
Staining was visualized by addition of streptavidin-HRP complex (Vector ABC elite) and DAB
substrate (Biogenex).
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FIG. 1.
Generation of founder tri-floxed endoglin mice. (A) Targeting the endoglin gene with trifloxed
(3fl) eng vector by homologous recombination in ES cells. Endoglin exons 5 and 6 and a PGK-
neo selection cassette are flanked by loxP sites (black arrowheads). The DNA used in the
targeting vector is drawn as a thick line and carries 1.3 and 5.7 kb homologous sequences in
the left and right arm, respectively. (B–D) Two successfully targeted ES clones (cl-6 and cl-19)
were recognized by genomic PCR using primers u and v to amplify a 1.8 kb product (B) and
(C) primers w and x to amplify a 500 bp product. Successful targeting was confirmed by
Southern Blotting using EcoRI digested genomic DNA hybridized with radiolabelled 3′ and
5′ external probes. The wild type (WT) EcoRI fragment (∼16 kb) is reduced in the targeted
allele (ta) to 3 kb at the 5′ end and ∼13 kb at the 3′ end.
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FIG. 2.
Removing the floxed neo cassette in vivo to generate bifloxed endoglin mice. (A) Breeding
strategy showing how the neo cassette was removed from the trifloxed mice using the Meu-
Cre40 transgenic line. (B) The bifloxed endoglin allele - with the neo cassette removed- was
recognized by PCR for a 566 bp product with primers y and z and readily discriminated from
the 411 bp product corresponding to the WT allele (upper panel). (The presence of the 1.8 kb
neo cassette in the tri-floxed allele precludes the formation of a detectable PCR product.) The
lower panel shows PCR products amplified with primers w and x to produce a 500 bp product
from all alleles with a loxP site in intron 6. PCR products corresponding to the bifloxed allele
can be seen at low levels in the mosaic (F1m) mouse, but increase to ∼50% in the F2 Eng2fl/
+ mouse. (C) Diagram summarizing conversion of the trifloxed allele (Eng3fl) to the required
bifloxed allele (Eng2fl), including position of diagnostic primers.
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FIG. 3.
Mice homozygous for the Eng Δex5-6 allele have an embryonic lethal phenotype and do not
express endoglin protein. (A) Diagram showing generation of the Eng Δex5-6 allele following
deletion of exons 5 and 6 in the presence of Cre, and position of primers w, x, and y. (B)
Multiplex PCR using primers w, x, and y produce a 602 bp product from the Eng Δex5-6 allele
and a 430 bp product from the wildtype allele. (C) EngΔ/Δ embryos at 9.5 dpc show
angiogenesis defects in the yolk sac compared with normal vessels (arrows) in their wild type
littermates. (D) Wholemount immunohistochemistry of wild type and EngΔ/Δ showing CD31
and endoglin expression. There is clear evidence of CD31 positive endothelial cells in the
EngΔ/Δembryos but endoglin protein was not detected.
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